The potential role of VPREB1 gene copy number variation in susceptibility to rheumatoid arthritis

Molecular Immunology

Volumn 48, Issue 11, 2011, Pages 1338-1343

  Yim, Seon Hee ^a   Chung, Yeun Jun ^a   Jin, Eun Heui ^b   Shim, Seung Cheol ^c   Kim, Ji Young ^c   Kim, Yong Shin ^b   Hu, Hae Jin ^a   Shin, Seung Hun ^a   Pae, Hyun Ock ^b   Zouali, Moncef ^d   Chung, Hun Tag ^e  

^a The Catholic University of Korea   (South Korea)

^b Wonkwang University   (South Korea)

^c Eulji University   (South Korea)

^d INSERM   (France)

^e University of Ulsan   (South Korea)

Author keywords

B cell; Copy number variation; Rheumatoid arthritis; VPREB1

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ADULT; AGED; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENE DOSAGE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK; VPREB1 GENE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS, SURROGATE; MALE; MIDDLE AGED; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE;

EID: 79956335923     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.11.009     Document Type: Review

References (30)

1. Docampo E., Rabionet R., Riveira-Muñoz E., Escaramís G., Julià A., Marsal S., Martín J.E., González-Gay M.A., Balsa A., Raya E., Martín J., Estivill X. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. Arthritis Rheum. 2010, 62:1246-1251.
2. Estivill X., Armengol L. Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet. 2007, 3:1787-1799.
3. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., Heward J.M., Gough S.C., de Smith A., Blakemore A.I., Froguel P., Owen C.J., Pearce S.H., Teixeira L., Guillevin L., Graham D.S., Pusey C.D., Cook H.T., Vyse T.J., Aitman T.J. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat. Genet. 2007, 39:721-723.
4. Fekete A., Soos L., Szekanecz Z., Szabo Z., Szodoray P., Barath S., Lakos G. Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. J. Autoimmun. 2007, 29:154-163.
5. Freeman J.L., Perry G.H., Feuk L., Redon R., McCarroll S.A., Altshuler D.M., Aburatani H., Jones K.W., Tyler-Smith C., Hurles M.E., Carter N.P., Scherer S.W., Lee C. Copy number variation: new insights in genome diversity. Genome Res. 2006, 16:949-961.
6. Gonzalez E., Kulkarni H., Bolivar H., Mangano A., Sanchez R., Catano G., Nibbs R.J., Freedman B.I., Quinones M.P., Bamshad M.J., Murthy K.K., Rovin B.H., Bradley W., Clark R.A., Anderson S.A., O'connell R.J., Agan B.K., Ahuja S.S., Bologna R., Sen L., Dolan M.J., Ahuja S.K. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005, 307:1434-1440.
7. Hollox E.J., Huffmeier U., Zeeuwen P.L., Palla R., Lascorz J., Rodijk-Olthuis D., van de Kerkhof P.C., Traupe H., de Jongh G., den Heijer M., Reis A., Armour J.A., Schalkwijk J. Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 2008, 40:23-25.
8. Imboden J.B. The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol. 2009, 4:417-434.
9. Keenan R.A., De Riva A., Corleis B., Hepburn L., Licence S., Winkler T.H., Mårtensson I.L. Censoring of autoreactive B cell development by the pre-B cell receptor. Science 2008, 321:696-699.
10. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., Silman A.J. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43:30-37.
11. Mamtani M., Anaya J.M., He W., Ahuja S.K. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010, 11:155-160.
12. McCarroll S.A., Altshuler D.M. Copy-number variation and association studies of human disease. Nat. Genet. 2007, 39:S37-S42.
13. McKinney C., Merriman M.E., Chapman P.T., Gow P.J., Harrison A.A., Highton J., Jones P.B., McLean L., O'Donnell J.L., Pokorny V., Spellerberg M., Stamp L.K., Willis J., Steer S., Merriman T.R. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann. Rheum. Dis. 2008, 67:409-413.
14. McLean-Tooke A., Spickett G.P., Gennery A.R. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand. J. Immunol. 2007, 66:1-7.
15. Melchers F. The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat. Rev. Immunol. 2005, 5:578-584.
16. Pelkonen P., Lahdenne P., Lantto R., Honkanen V. Chronic arthritis associated with chromosome deletion 22q11.2 syndrome. J. Rheumatol. 2002, 29:2648-2650.
17. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., Liew A., Khalili H., Chandrasekaran A., Davies L.R., Li W., Tan A.K., Bonnard C., Ong R.T., Thalamuthu A., Pettersson S., Liu C., Tian C., Chen W.V., Carulli J.P., Beckman E.M., Altshuler D., Alfredsson L., Criswell L.A., Amos C.I., Seldin M.F., Kastner D.L., Klareskog L., Gregersen P.K. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N. Engl. J. Med. 2007, 357:1199-1209.
18. Raychaudhuri S., Thomson B.P., Remmers E.F., Eyre S., Hinks A., Guiducci C., Catanese J.J., Xie G., Stahl E.A., Chen R., Alfredsson L., Amos C.I., Ardlie K.G., Consortium BIRAC., Barton A., Bowes J., Burtt N.P., Chang M., Coblyn J., Costenbader K.H., Criswell L.A., Crusius J.B., Cui J., De Jager P.L., Ding B., Emery P., Flynn E., Harrison P., Hocking L.J., Huizinga T.W., Kastner D.L., Ke X., Kurreeman F.A., Lee A.T., Liu X., Li Y., Martin P., Morgan A.W., Padyukov L., Reid D.M., Seielstad M., Seldin M.F., Shadick N.A., Steer S., Tak P.P., Thomson W., van der Helm-van Mil A.H., van der Horst-Bruinsma I.E., Weinblatt M.E., Wilson A.G., Wolbink G.J., Wordsworth P., Consortium Y.E.A.R., Altshuler D., Karlson E.W., Toes R.E., de Vries N., Begovich A.B., Siminovitch K.A., Worthington J., Klareskog L., Gregersen P.K., Daly M.J., Plenge R.M. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 2009, 41:1313-1318.
19. Roll P., Dorner T., Tony H.P. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum. 2008, 58:1566-1575.
20. Samuels J., Ng Y.S., Coupillaud C., Paget D., Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 2005, 201:1659-1667.
21. Schaschl H., Aitman T.J., Vyse T.J. Copy number variation in the human genome and its implication in autoimmunity. Clin. Exp. Immunol. 2009, 156:12-16.
22. Shimizu T., Mundt C., Licence S., Melchers F., Martensson I.L. VpreB1/VpreB2/lambda 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J. Immunol. 2002, 168:6286-6293.
23. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., Lipsky P.E. Identification and characterization of circulating human transitional B cells. Blood 2005, 105:4390-4398.
24. Sirota M., Schaub M.A., Batzoglou S., Robinson W.H., Butte A.J. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet. 2009, 5:e1000792.
25. Sullivan K.E., McDonald-McGinn D.M., Driscoll D.A., Zmijewski C.M., Ellabban A.S., Reed L., Emanuel B.S., Zackai E.H., Athreya B.H., Keenan G. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum. 1997, 40:430-436.
26. van Loo P.F., Dingjan G.M., Maas A., Hendriks R.W. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity 2007, 27:468-480.
27. Viau M., Zouali M. B-lymphocytes, innate immunity, and autoimmunity. Clin. Immunol. 2005, 114:17-26.
28. Yamada R., Yamamoto K. Mechanisms of disease: genetics of rheumatoid arthritis-ethnic differences in disease-associated genes. Nat. Clin. Pract. Rheumatol. 2007, 11:644-650.
29. Yim S.H., Kim T.M., Hu H.J., Kim J.H., Kim B.J., Lee J.Y., Han B.G., Shin S.H., Jung S.H., Chung Y.J. Copy number variations in East-Asian population and their evolutionary and functional implications. Hum. Mol. Genet. 2010, 19:1001-1008.
30. Zouali M. B lymphocytes-chief players and therapeutic targets in autoimmune diseases. Front Biosci. 2008, 13:4852-4861.